Atrial Fibrillation (Management of) 2010 and Focused Update (2012)

ESC Clinical Practice Guidelines

Topics: Atrial Fibrillation

Summary

Professor Bax talks about the ESC Guidelines

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population.

25/08/2012 00:00:00

Current versions available to download

Publication date	Versions	References	Size
2010	Full Text	European Heart Journal (31):2369-2429 - doi:10.1093/eurheartj/ehq278	3 MB
2011	Corrigendum	doi:10.1093/eurheartj/ehq512	106 KB
2012	Full Text	European Heart Journal 2012;33:2719-2747 - doi:10.1093/eurheartj/ehs253	1 MB
2012	Corrigendum	Corrigendum-AFib-Focused-Update-2012-EHJ-doi:10.1093/eurheartj/eht027	62 KB
2012	Pocket guidelines	Table of Contents
	Pda	Download the PDA version
2011	Slideset	2010 Guidelines slides on AFIB	9 MB
2012	Slideset	Slides AFIB focused update 2012	3 MB
	CME Questions	CME Questions AFIB
	Related Materials	AFIB - Additional References	2 MB
2011	Related Materials	ESC Statement on Dronedarore	45 KB

Current translated versions available to download:

Authors

Focused update 2012
A. John Camm (Chairperson),Gregory Y.H. Lip, Dan Atar, Raffaele de Caterina, Gerhard Hindricks, Stefan Hohnloser, Paulus Kirchhof, Irina Savelieva

Version 2010
A. John Camm FESC (Chairperson), Paulus Kirchhof FESC, Gregory Y. H. Lip FESC, Ulrich Schotten, Irene Savelieva, Sabine Ernst FESC, Isabelle C. Van Gelder FESC, Nawwar Al-Attar, Gerhard Hindricks FESC, Bernard Prendergast FESC, Hein Heidbuchel FESC, Ottavio Alfieri FESC, Annalisa Angelini FESC, Dan Atar FESC, Paolo Colonna FESC, Raffaele De Caterina FESC, Johan De Sutter FESC, Andreas Goette, Bulent Gorenek FESC, Magnus Heldal FESC, Stefan Hohnloser FESC, Philippe Kolh FESC, Jean-Yves Le Heuzey FESC, Piotr Ponikowski FESC, Frans H. Rutten

Declarations of Interest of the experts involved in the elaboration of the 2010 document.

Declarations of Interest of the experts involved in the elaboration of the 2012 document.

Endorsed by:

Table of contents: Focused Update (2012)

Preamble
Introduction
Stroke and bleeting risk assessment
New oral anticoagulants
Left atrial appndage closure
Cardioversion with pharmacological agents
Catheter ablation of atrial fibrillation
Concluding remarks

Table of contents: Full Text 2010 (ESC Clinical Practice Guidelines)

Abbreviations and acronyms

Preamble

Introduction

Epidemiology
Mechanisms of atrial fibrillation

Detection, 'natural' history and acute management

Definition
Detection
"Natural" time course
Electrocardiogram techniques to diagnose and monitor atrial fibrillation
Types of atrial fibrillation
Initial management
Clinical follow-up

Management

Antithrombotic management

Risk stratification for stroke and thrombo-embolism
Antithrombotic therapy
Anticoagulation therapy with vitamin K antagonist vs control
Antiplatelet therapy vs control
Anticoagulation therapy with vitamin k antagonist vs antiplatelet therapy
Other antithrombotic drug regimens
Investigational agents
Current recommendations for antithrombotic therapy
Risk of bleeding
Optimal international normalized ratio
Special situations
paroxymal atrial fibrilllation
Perioperative anticoagulation
Stable vascular disease
ACS and/ or PCI
Elective PCI
Non-St elevation myocardial infraction
Acute ST segment elevation myocardial infarction with primary percutaneous intervention
Acute stroke
Atrial flutter
Cardioversion
Tansoesophageal echocardiogram-guided cardioversion
Non-pharmacological methods to prevent stroke